108 related articles for article (PubMed ID: 19875755)
21. P53 expression is a factor for prognostic assessment in breast sarcoma.
Maciel Mdo S; Viegas LC; Nonogaki S; Nishimoto IN; Abrão FS; Mourão Neto M; Brentani MM
Breast Cancer Res Treat; 2002 Feb; 71(3):193-202. PubMed ID: 12002339
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma.
Liang Y; Wang W; Que Y; Guan Y; Xiao W; Fang C; Zhang X; Zhou Z
BMC Cancer; 2018 Oct; 18(1):942. PubMed ID: 30285656
[TBL] [Abstract][Full Text] [Related]
23. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of postoperative radiotherapy in localized primary soft tissue sarcoma treated with conservative surgery.
Zhao RP; Yu XL; Zhang Z; Jia LJ; Feng Y; Yang ZZ; Chen XX; Wang J; Ma SL; Guo XM
Radiat Oncol; 2016 Feb; 11():25. PubMed ID: 26911328
[TBL] [Abstract][Full Text] [Related]
25. Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patients.
Wichmann H; Güttler A; Bache M; Taubert H; Vetter M; Würl P; Holzhausen HJ; Eckert AW; Kappler M; Vordermark D
Strahlenther Onkol; 2014 Oct; 190(10):912-8. PubMed ID: 24715245
[TBL] [Abstract][Full Text] [Related]
26. Expression of HER2/neu does not correlate with survival in soft tissue sarcoma.
Sato T; Peiper M; Heinecke A; Zurakowski D; Eisenberger CF; Hosch S; Knoefel WT; Izbicki JR
Onkologie; 2003 Jun; 26(3):268-71. PubMed ID: 12845212
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
Kim C; Kim EK; Jung H; Chon HJ; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim SH; Kim HS
BMC Cancer; 2016 Jul; 16():434. PubMed ID: 27393385
[TBL] [Abstract][Full Text] [Related]
28. Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase-2 and sialyl Lewis x antigen.
Gunawardena I; Arendse M; Jameson MB; Plank LD; Gregor RT
ANZ J Surg; 2015 Nov; 85(11):843-8. PubMed ID: 24171785
[TBL] [Abstract][Full Text] [Related]
29. Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study.
Posch F; Partl R; Döller C; Riedl JM; Smolle M; Leitner L; Bergovec M; Liegl-Atzwanger B; Stotz M; Bezan A; Gerger A; Pichler M; Kapp KS; Stöger H; Leithner A; Szkandera J
Ann Surg Oncol; 2018 Mar; 25(3):776-783. PubMed ID: 28895087
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors.
Menezes HL; Jucá MJ; Gomes EG; Nunes BL; Costa HO; Matos D
Arq Gastroenterol; 2010; 47(2):141-7. PubMed ID: 20721457
[TBL] [Abstract][Full Text] [Related]
31. Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract.
Scarpini S; Rouprêt M; Renard-Penna R; Camparo P; Cussenot O; Compérat E
Urol Oncol; 2012; 30(2):182-7. PubMed ID: 20189840
[TBL] [Abstract][Full Text] [Related]
32. Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer.
Skirnisdottir I; Seidal T
Cancer Genomics Proteomics; 2013; 10(1):27-34. PubMed ID: 23382584
[TBL] [Abstract][Full Text] [Related]
33. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.
Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT
Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of newer prognostic markers for adult soft tissue sarcomas.
Levine EA; Holzmayer T; Bacus S; Mechetner E; Mera R; Bolliger C; Roninson IB; Das Gupta TK
J Clin Oncol; 1997 Oct; 15(10):3249-57. PubMed ID: 9336362
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors for survival in patients with locally recurrent extremity soft tissue sarcomas.
Eilber FC; Brennan MF; Riedel E; Alektiar KM; Antonescu CR; Singer S
Ann Surg Oncol; 2005 Mar; 12(3):228-36. PubMed ID: 15827815
[TBL] [Abstract][Full Text] [Related]
36. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
Choi ES; Kim HS; Han I
Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668
[TBL] [Abstract][Full Text] [Related]
37. Local recurrence is correlated with decreased overall survival in patients with intermediate high-grade localized primary soft tissue sarcoma of extremity and abdominothoracic wall.
Zhao R; Yu X; Feng Y; Yang Z; Chen X; Wand J; Ma S; Zhang Z; Guo X
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e109-e115. PubMed ID: 29071781
[TBL] [Abstract][Full Text] [Related]
38. Study of biomolecular and clinical prognostic factors in patients with cancer of the vulva undergoing surgical treatment.
Zanvettor PH; Filho DF; Soares FA; Neves AR; Palmeira LO
Int J Gynecol Cancer; 2014 May; 24(4):766-72. PubMed ID: 24552893
[TBL] [Abstract][Full Text] [Related]
39. Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.
Sun X; Sun Z; Zhu Z; Li C; Zhang J; Xu H; Sun M
Tumour Biol; 2015 Sep; 36(10):7521-30. PubMed ID: 25913622
[TBL] [Abstract][Full Text] [Related]
40. [Expression and clinical significance of metastasis-related tumor markers in colorectal cancer].
Wan XB; Pan ZZ; Ren YK; Ding PR; Chen G; Wan DS
Ai Zheng; 2009 Sep; 28(9):950-4. PubMed ID: 19728913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
